TG and COVID-19: This systematic review confirmed that thyroid hormone levels, especially FT3 levels, were reduced in patients with COVID-19, compared to the healthy cohort, and this alteration was more evident in severe COVID-19 patients with pneumonia compared to those without pneumonia, indicating that decreased FT3 levels have clinical significance for the prognosis of this condition.